title: [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
authors.forename: B R
authors.initials: BR
authors.lastname: Bloem
authors.forename: D W
authors.initials: DW
authors.lastname: Roofthooft
authors.forename: G J
authors.initials: GJ
authors.lastname: Lammers
authors.forename: A J
authors.initials: AJ
authors.lastname: de Beaufort
authors.forename: O F
authors.initials: OF
authors.lastname: Brouwer
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride